This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Jul;51(1):1-3.

doi: 10.1016/j.jhep.2009.04.007. Epub 2009 May 3.

Treatment with nucleos(t)ide analogues in chronic hepatitis B: where does the road map lead us?

Harry L A Janssen, Jurriën G P Reijnders

PMID: 19443071
DOI: 10.1016/j.jhep.2009.04.007

Free article

Editorial

Treatment with nucleos(t)ide analogues in chronic hepatitis B: where does the road map lead us?

Harry L A Janssen et al. J Hepatol. 2009 Jul.

Free article

. 2009 Jul;51(1):1-3.

doi: 10.1016/j.jhep.2009.04.007. Epub 2009 May 3.

Authors

Harry L A Janssen, Jurriën G P Reijnders

PMID: 19443071
DOI: 10.1016/j.jhep.2009.04.007

No abstract available

PubMed Disclaimer

Comment on

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.
Zeuzem S, Gane E, Liaw YF, Lim SG, DiBisceglie A, Buti M, Chutaputti A, Rasenack J, Hou J, O'Brien C, Nguyen TT, Jia J, Poynard T, Belanger B, Bao W, Naoumov NV. Zeuzem S, et al. J Hepatol. 2009 Jul;51(1):11-20. doi: 10.1016/j.jhep.2008.12.019. Epub 2009 Feb 12. J Hepatol. 2009. PMID: 19345439 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science